Background: Androgen production following exercise has been suggested to contribute anabolic actions of muscle. However, the underlying mechanisms of the androgen receptor (AR) in androgen’s action are still unclear. Objective: In the present study, we examined androgen/AR-mediated action in exercise, especially for the suppression of myostatin, a potent negative regulator of muscle mass. Methods: To examine the effects of exercise, we employed low-intensity exercise in mice and electric pulse stimulation (EPS) in C2C12 myotubes. Androgen production by C2C12 myotubes was measured by enzyme-linked immunosorbent assay. To block the action of AR, we pretreated C2C12 myotubes with flutamide. Quantitative real-time polymerase chain reaction was used to determine the expression levels of proteolytic genes including CCAAT/enhancer-binding protein delta (C/EBPδ), myostatin and muscle E3 ubiquitin ligases, as well as myogenic genes such as myogenin and PGC1α. The activation of 5′-adenosine-activated protein kinase and STAT3 was determined by Western blot analysis. Results: Both mRNA and protein levels of AR significantly increased in skeletal muscle of low-intensity exercised mice and C2C12 myotubes exposed to EPS. Production of testosterone and dihydrotestosterone from EPS-treated C2C12 myotubes was markedly increased. Of interest, we found that myostatin was clearly inhibited by EPS, and its inhibition was significantly abrogated when AR was blocked by flutamide. To test how AR suppresses myostatin, we examined the effects of EPS on C/EBPδ because the promoter region of myostatin has several C/EBP recognition sites. C/EBPδ expression was decreased by EPS, and this decrease was negated by flutamide. IL-6 and phospho-STAT3 (pSTAT3) expression, the downstream pathway of myostatin, were decreased by EPS and this was also reversed by flutamide. Similar downregulation of C/EBPδ, myostatin, and IL-6 was seen in skeletal muscle of low-intensity exercised mice. Conclusions: Muscle AR expression and androgen production were increased by exercise and EPS treatment. As a mechanistical insight, it is suggested that AR inhibited myostatin expression transcriptionally by C/EBPδ suppression, which negatively influences IL-6/pSTAT3 expression and consequently contributes to the prevention of muscle proteolysis during exercise.

1.
Akimoto
T
,
Pohnert
SC
,
Li
P
,
Zhang
M
,
Gumbs
C
,
Rosenberg
PB
, et al
Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway
.
J Biol Chem
.
2005
May
;
280
(
20
):
19587
93
.
[PubMed]
0021-9258
2.
Alessio
HM
,
Goldfarb
AH
.
Lipid peroxidation and scavenger enzymes during exercise: adaptive response to training
.
J Appl Physiol (1985)
.
1988
Apr
;
64
(
4
):
1333
6
.
[PubMed]
8750-7587
3.
Staron
RS
,
Leonardi
MJ
,
Karapondo
DL
,
Malicky
ES
,
Falkel
JE
,
Hagerman
FC
, et al
Strength and skeletal muscle adaptations in heavy-resistance-trained women after detraining and retraining
.
J Appl Physiol (1985)
.
1991
Feb
;
70
(
2
):
631
40
.
[PubMed]
8750-7587
4.
Willoughby
DS
,
Taylor
L
.
Effects of sequential bouts of resistance exercise on androgen receptor expression
.
Med Sci Sports Exerc
.
2004
Sep
;
36
(
9
):
1499
506
.
[PubMed]
0195-9131
5.
Rynders
CA
,
Weltman
JY
,
Jiang
B
,
Breton
M
,
Patrie
J
,
Barrett
EJ
, et al
Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults
.
J Clin Endocrinol Metab
.
2014
Jan
;
99
(
1
):
220
8
.
[PubMed]
0021-972X
6.
Richter
EA
,
Hargreaves
M
.
Exercise, GLUT4, and skeletal muscle glucose uptake
.
Physiol Rev
.
2013
Jul
;
93
(
3
):
993
1017
.
[PubMed]
0031-9333
7.
Ma
Y
,
Qiang
L
,
He
M
.
Exercise therapy augments the ischemia-induced proangiogenic state and results in sustained improvement after stroke
.
Int J Mol Sci
.
2013
Apr
;
14
(
4
):
8570
84
.
[PubMed]
1661-6596
8.
Simpson
RJ
,
Kunz
H
,
Agha
N
,
Graff
R
.
Exercise and the regulation of immune functions
.
Prog Mol Biol Transl Sci
.
2015
;
135
:
355
80
.
[PubMed]
1877-1173
9.
Simpson
RJ
,
Lowder
TW
,
Spielmann
G
,
Bigley
AB
,
LaVoy
EC
,
Kunz
H
.
Exercise and the aging immune system
.
Ageing Res Rev
.
2012
Jul
;
11
(
3
):
404
20
.
[PubMed]
1568-1637
10.
Ponjee
GA
,
De Rooy
HA
,
Vader
HL
.
Androgen turnover during marathon running
.
Med Sci Sports Exerc
.
1994
Oct
;
26
(
10
):
1274
7
.
[PubMed]
0195-9131
11.
Tarpenning
KM
,
Wiswell
RA
,
Hawkins
SA
,
Marcell
TJ
.
Influence of weight training exercise and modification of hormonal response on skeletal muscle growth
.
J Sci Med Sport
.
2001
Dec
;
4
(
4
):
431
46
.
[PubMed]
1440-2440
12.
Aizawa
K
,
Iemitsu
M
,
Maeda
S
,
Otsuki
T
,
Sato
K
,
Ushida
T
, et al
Acute exercise activates local bioactive androgen metabolism in skeletal muscle
.
Steroids
.
2010
Mar
;
75
(
3
):
219
23
.
[PubMed]
0039-128X
13.
Amory
JK
.
Study clarifies associations between hypogonadism and health in aging men
.
Asian J Androl
.
2012
Nov
;
14
(
6
):
809
10
.
[PubMed]
1008-682X
14.
Rossetti
ML
,
Steiner
JL
,
Gordon
BS
.
Androgen-mediated regulation of skeletal muscle protein balance
.
Mol Cell Endocrinol
.
2017
May
;
447
:
35
44
.
[PubMed]
0303-7207
15.
Serra
C
,
Sandor
NL
,
Jang
H
,
Lee
D
,
Toraldo
G
,
Guarneri
T
, et al
The effects of testosterone deprivation and supplementation on proteasomal and autophagy activity in the skeletal muscle of the male mouse: differential effects on high-androgen responder and low-androgen responder muscle groups
.
Endocrinology
.
2013
Dec
;
154
(
12
):
4594
606
.
[PubMed]
0013-7227
16.
De Naeyer
H
,
Lamon
S
,
Russell
AP
,
Everaert
I
,
De Spaey
A
,
Vanheel
B
, et al
Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice
.
Eur J Appl Physiol
.
2014
Apr
;
114
(
4
):
751
61
.
[PubMed]
1439-6319
17.
Ferrando
AA
,
Sheffield-Moore
M
,
Yeckel
CW
,
Gilkison
C
,
Jiang
J
,
Achacosa
A
, et al
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms
.
Am J Physiol Endocrinol Metab
.
2002
Mar
;
282
(
3
):
E601
7
.
[PubMed]
0193-1849
18.
Ferrando
AA
,
Sheffield-Moore
M
,
Paddon-Jones
D
,
Wolfe
RR
,
Urban
RJ
.
Differential anabolic effects of testosterone and amino acid feeding in older men
.
J Clin Endocrinol Metab
.
2003
Jan
;
88
(
1
):
358
62
.
[PubMed]
0021-972X
19.
Zimmers
TA
,
Davies
MV
,
Koniaris
LG
,
Haynes
P
,
Esquela
AF
,
Tomkinson
KN
, et al
Induction of cachexia in mice by systemically administered myostatin
.
Science
.
2002
May
;
296
(
5572
):
1486
8
.
[PubMed]
0036-8075
20.
McPherron
AC
,
Lawler
AM
,
Lee
SJ
.
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
.
Nature
.
1997
May
;
387
(
6628
):
83
90
.
[PubMed]
0028-0836
21.
Clop
A
,
Marcq
F
,
Takeda
H
,
Pirottin
D
,
Tordoir
X
,
Bibé
B
, et al
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep
.
Nat Genet
.
2006
Jul
;
38
(
7
):
813
8
.
[PubMed]
1061-4036
22.
Grobet
L
,
Martin
LJ
,
Poncelet
D
,
Pirottin
D
,
Brouwers
B
,
Riquet
J
, et al
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle
.
Nat Genet
.
1997
Sep
;
17
(
1
):
71
4
.
[PubMed]
1061-4036
23.
Schuelke
M
,
Wagner
KR
,
Stolz
LE
,
Hübner
C
,
Riebel
T
,
Kömen
W
, et al
Myostatin mutation associated with gross muscle hypertrophy in a child
.
N Engl J Med
.
2004
Jun
;
350
(
26
):
2682
8
.
[PubMed]
0028-4793
24.
Kawada
S
,
Ishii
N
.
Testosterone causes decrease in the content of skeletal muscle myostatin
.
Int J Sport Health Sci
.
2006
;
4
:
44
8
. 1348-1509
25.
Hulmi
JJ
,
Ahtiainen
JP
,
Selänne
H
,
Volek
JS
,
Häkkinen
K
,
Kovanen
V
, et al
Androgen receptors and testosterone in men—effects of protein ingestion, resistance exercise and fiber type
.
J Steroid Biochem Mol Biol
.
2008
May
;
110
(
1-2
):
130
7
.
[PubMed]
0960-0760
26.
Zhang
L
,
Pan
J
,
Dong
Y
,
Tweardy
DJ
,
Dong
Y
,
Garibotto
G
, et al
Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass
.
Cell Metab
.
2013
Sep
;
18
(
3
):
368
79
.
[PubMed]
1550-4131
27.
Ma
K
,
Mallidis
C
,
Artaza
J
,
Taylor
W
,
Gonzalez-Cadavid
N
,
Bhasin
S
.
Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro
.
Am J Physiol Endocrinol Metab
.
2001
Dec
;
281
(
6
):
E1128
36
.
[PubMed]
0193-1849
28.
Allen
DL
,
Cleary
AS
,
Hanson
AM
,
Lindsay
SF
,
Reed
JM
.
CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro
.
Am J Physiol Regul Integr Comp Physiol
.
2010
Dec
;
299
(
6
):
R1592
601
.
[PubMed]
0363-6119
29.
Akira
S
,
Isshiki
H
,
Sugita
T
,
Tanabe
O
,
Kinoshita
S
,
Nishio
Y
, et al
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
.
EMBO J
.
1990
Jun
;
9
(
6
):
1897
906
.
[PubMed]
0261-4189
30.
Poli
V
.
The role of C/EBP isoforms in the control of inflammatory and native immunity functions
.
J Biol Chem
.
1998
Nov
;
273
(
45
):
29279
82
.
[PubMed]
0021-9258
31.
Dubois
V
,
Laurent
MR
,
Sinnesael
M
,
Cielen
N
,
Helsen
C
,
Clinckemalie
L
, et al
A satellite cell-specific knockout of the androgen receptor reveals myostatin as a direct androgen target in skeletal muscle
.
FASEB J
.
2014
Jul
;
28
(
7
):
2979
94
.
[PubMed]
0892-6638
32.
McGee
SL
,
Hargreaves
M
.
AMPK-mediated regulation of transcription in skeletal muscle
.
Clin Sci (Lond)
.
2010
Jan
;
118
(
8
):
507
18
.
[PubMed]
0143-5221
33.
da Rocha
AL
,
Teixeira
GR
,
Pinto
AP
,
de Morais
GP
,
Oliveira
LD
,
de Vicente
LG
, et al
Excessive training induces molecular signs of pathologic cardiac hypertrophy
.
J Cell Physiol
.
2018
Nov
;
233
(
11
):
8850
61
.
[PubMed]
0021-9541
34.
Zhang
L
,
Rajan
V
,
Lin
E
,
Hu
Z
,
Han
HQ
,
Zhou
X
, et al
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
.
FASEB J
.
2011
May
;
25
(
5
):
1653
63
.
[PubMed]
0892-6638
35.
Hughes
DC
,
Stewart
CE
,
Sculthorpe
N
,
Dugdale
HF
,
Yousefian
F
,
Lewis
MP
, et al
Testosterone enables growth and hypertrophy in fusion impaired myoblasts that display myotube atrophy: deciphering the role of androgen and IGF-I receptors
.
Biogerontology
.
2016
Jun
;
17
(
3
):
619
39
.
[PubMed]
1389-5729
36.
Siriett
V
,
Nicholas
G
,
Berry
C
,
Watson
T
,
Hennebry
A
,
Thomas
M
, et al
Myostatin negatively regulates the expression of the steroid receptor co-factor ARA70
.
J Cell Physiol
.
2006
Jan
;
206
(
1
):
255
63
.
[PubMed]
0021-9541
37.
Monks
DA
,
O’Bryant
EL
,
Jordan
CL
.
Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction
.
J Comp Neurol
.
2004
May
;
473
(
1
):
59
72
.
[PubMed]
0021-9967
38.
Jia
L
,
Berman
BP
,
Jariwala
U
,
Yan
X
,
Cogan
JP
,
Walters
A
, et al
Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity
.
PLoS One
.
2008
;
3
(
11
):
e3645
.
[PubMed]
1932-6203
39.
Wang
Q
,
Li
W
,
Liu
XS
,
Carroll
JS
,
Jänne
OA
,
Keeton
EK
, et al
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
.
Mol Cell
.
2007
Aug
;
27
(
3
):
380
92
.
[PubMed]
1097-2765
40.
Massie
CE
,
Adryan
B
,
Barbosa-Morais
NL
,
Lynch
AG
,
Tran
MG
,
Neal
DE
, et al
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
.
EMBO Rep
.
2007
Sep
;
8
(
9
):
871
8
.
[PubMed]
1469-221X
41.
Wyce
A
,
Bai
Y
,
Nagpal
S
,
Thompson
CC
.
Research Resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function
.
Mol Endocrinol
.
2010
Aug
;
24
(
8
):
1665
74
.
[PubMed]
0888-8809
42.
Zhang
Y
,
Sif
S
,
DeWille
J
.
The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression
.
J Cell Biochem
.
2007
Dec
;
102
(
5
):
1256
70
.
[PubMed]
0730-2312
43.
Yan
C
,
Johnson
PF
,
Tang
H
,
Ye
Y
,
Wu
M
,
Gao
H
.
CCAAT/enhancer-binding protein δ is a critical mediator of lipopolysaccharide-induced acute lung injury
.
Am J Pathol
.
2013
Feb
;
182
(
2
):
420
30
.
[PubMed]
0002-9440
44.
Litvak
V
,
Ramsey
SA
,
Rust
AG
,
Zak
DE
,
Kennedy
KA
,
Lampano
AE
, et al
Role of the transcription factor C/EBPδ in a regulatory circuit that discriminates between transient and persistent Toll-like receptor 4-induced signals
.
Nat Immunol
.
2009
;
10
:
437
43
.
[PubMed]
1529-2908
45.
Nindl
BC
,
Kraemer
WJ
,
Gotshalk
LA
,
Marx
JO
,
Volek
JS
,
Bush
FA
, et al
Testosterone responses after resistance exercise in women: influence of regional fat distribution
.
Int J Sport Nutr Exerc Metab
.
2001
Dec
;
11
(
4
):
451
65
.
[PubMed]
1526-484X
46.
Copeland
JL
,
Consitt
LA
,
Tremblay
MS
.
Hormonal responses to endurance and resistance exercise in females aged 19-69 years
.
J Gerontol A Biol Sci Med Sci
.
2002
Apr
;
57
(
4
):
B158
65
.
[PubMed]
1079-5006
47.
Linnamo
V
,
Pakarinen
A
,
Komi
PV
,
Kraemer
WJ
,
Häkkinen
K
.
Acute hormonal responses to submaximal and maximal heavy resistance and explosive exercises in men and women
.
J Strength Cond Res
.
2005
Aug
;
19
(
3
):
566
71
.
[PubMed]
1064-8011
48.
Kraemer
WJ
,
Fleck
SJ
,
Dziados
JE
,
Harman
EA
,
Marchitelli
LJ
,
Gordon
SE
, et al
Changes in hormonal concentrations after different heavy-resistance exercise protocols in women
.
J Appl Physiol (1985)
.
1993
Aug
;
75
(
2
):
594
604
.
[PubMed]
8750-7587
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.